We are international
Donate
• meetings TEXT SIZE   


Inaugural IMF-China Myeloma Symposium; Advances in Diagnosis and Treatment
October 20, 2007
Sat, Oct 20, 2007

Where:
Regent Hotel
Beijing, China




IMF CHINA MYELOMA SYMPOSIUM MEETING AGENDA
TIME
TOPIC
PRESENTER(S)

7:00 AM – 8:00 AM Breakfast

8:00 AM – 8:10 AM Welcome, Opening Remarks and Introductions Brian Durie

8:10 AM – 8:55 AM Myeloma 2007
  • Biology
  • Etiology and epidemiology
  • Staging
  • Clinical Applications of New Technologies
Brian Durie

8:55 PM – 9:40 PM New Technologies in Diagnosis and Prognosis
  • Genomics and Proteomics
  • Serum Free Light Chain Immunoassay
  • Biomarkers as Treatment and Prognosis Factors
  • Questions and Answers
Wen-Ming Chen

9:40 AM – 10:25 AM Current Approach to Frontline Therapy
  • Traditional therapies
  • Novel therapies
    • Thalidomide
    • Bortezomib
    • Lenalidomide
    • Identifying Targets for Novel Therapies
  • Questions and Answers
Sundar Jagannath

10:25 AM – 10:45 AM Morning Break

10:45 AM – 11:30 AM Current Status of Multiple Myeloma: Perspective from China
  • Incidence and Features of Myeloma
  • Treatment Modalities in China
  • Future Directions
  • Questions and Answers
Jian Hou

11:30 AM – 12:15 PM Experience with a Novel Myeloma Therapy in China
  • Clinical Application of Bortezomib in Chinese Multiple Myeloma Patients
  • Bortezomib in Refractory and Relapsed Patients
  • Learnings and Future Directions
  • Questions and Answers
Xiao-Jun Huang

12:15 PM – 1:15 PM Lunch

1:15 PM – 2:00PM Role of High Dose Therapy and Transplant in Myeloma
  • Current Trends in High Dose Therapy
  • Transplant in Myeloma Patients
    • Autologous Transplantation
    • Allogeneic Transplantation: Perfect match or Mismatch of an Allele
  • Questions and Answers
Mario Boccadoro

2:00 PM – 2:45 PM Current Clinical Research in Multiple Myeloma
  • Combination Modalities of Novel Therapies
  • Treatment of Refractory and Relapsed Multiple Myeloma
  • Ongoing Clinical Trials on Bortezomib
  • Questions and Answers
Brian Durie

2:45 PM – 3:05 PM Afternoon Break

3:05 PM – 3:50 PM Panel Discussions
  • How to Improve Therapeutic Outcomes for Multiple Myeloma Patients
  • Potential Collaborations with Chinese Investigators
All Faculty

3:50 PM – 4:00 PM Closing Remarks Brian Durie